Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$501M |
| 2 |
UnitedHealth
UNH
|
+$307M |
| 3 |
Global Payments
GPN
|
+$302M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$279M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$433M |
| 2 |
Lam Research
LRCX
|
+$373M |
| 3 |
Pfizer
PFE
|
+$354M |
| 4 |
Verizon
VZ
|
+$341M |
| 5 |
EA
Electronic Arts
EA
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.18% |
| 2 | Healthcare | 10.69% |
| 3 | Financials | 10.58% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
Quantum-Si Incorporated
QSI
$179M
| $39.4K | ﹤0.01% |
+23,744
| New | +$57.2K |
|
3777
Kodiak Sciences
KOD
$2.64B
| $38.1K | ﹤0.01% |
21,170
-264,585
| -93% | -$934K |
|
|
TELL
3778
DELISTED
Tellurian Inc.
TELL
| $36.9K | ﹤0.01% |
31,822
-2,766
| -8% | -$3.76K |
|
3779
Century Therapeutics
IPSC
$372M
| $36.8K | ﹤0.01% |
18,400
| – | – |
|
3780
FuelCell Energy
FCEL
$1.54B
| $35.2K | ﹤0.01% |
916
+308
| +51% | +$16.1K |
|
3781
Oxbridge Re Holdings
OXBR
$10.5M
| $35K | ﹤0.01% |
25,000
+10,000
| +67% | +$13.9K |
|
|
BCOV
3782
DELISTED
Brightcove, Inc.
BCOV
| $34.6K | ﹤0.01% |
+10,510
| New | +$40.5K |
|
|
TSP
3783
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $32.6K | ﹤0.01% |
20,929
-60,034
| -74% | -$105K |
|
3784
DHI Group
DHX
$166M
| $31.1K | ﹤0.01% |
10,178
-7,125
| -41% | -$25.4K |
|
|
LONA
3785
LeonaBio Inc
LONA
$71.6M
| $30.9K | ﹤0.01% |
1,530
| – | – |
|
3786
Lineage Cell Therapeutics
LCTX
$283M
| $30.3K | ﹤0.01% |
25,660
-14
| -0.1% | -$19 |
|
|
DZSI
3787
DELISTED
DZS Inc. Common Stock
DZSI
| $29.9K | ﹤0.01% |
+14,218
| New | +$40.9K |
|
3788
Altimmune
ALT
$583M
| $28.3K | ﹤0.01% |
10,891
-764
| -7% | -$2.19K |
|
3789
Quantum Corp
QMCO
$764M
| $25.6K | ﹤0.01% |
2,101
| – | – |
|
3790
Denison Mines
DNN
$3B
| $24.8K | ﹤0.01% |
15,000
-609
| -4% | -$843 |
|
3791
Beyond Air
XAIR
$4.21M
| $24.5K | ﹤0.01% |
27
-12
| -31% | -$15.8K |
|
|
KLRS
3792
Kalaris Therapeutics
KLRS
$94.5M
| $23K | ﹤0.01% |
+466
| New | +$31.8K |
|
3793
Retractable Technologies
RVP
$20.3M
| $21.4K | ﹤0.01% |
18,006
-7,950
| -31% | -$9.35K |
|
3794
Barnes & Noble Education
BNED
$435M
| $20K | ﹤0.01% |
184
-49
| -21% | -$6.63K |
|
3795
CEL-SCI Corp
CVM
$26.6M
| $19.4K | ﹤0.01% |
517
| – | – |
|
|
EGIO
3796
DELISTED
Edgio, Inc. Common Stock
EGIO
| $18.2K | ﹤0.01% |
+534
| New | +$16.7K |
|
3797
Scilex Holding
SCLX
$47.2M
| $17.8K | ﹤0.01% |
362
-5
| -1% | -$685 |
|
3798
Nkarta
NKTX
$167M
| $14.5K | ﹤0.01% |
10,403
-6,883
| -40% | -$13.1K |
|
3799
Gevo
GEVO
$403M
| $14.3K | ﹤0.01% |
12,031
+1,000
| +9% | +$1.48K |
|
|
HLTH
3800
DELISTED
Cue Health Inc. Common Stock
HLTH
| $13.4K | ﹤0.01% |
30,345
| – | – |
|
Similar funds
Ameriprise's Q3 2023 Portfolio in Review
As of Q3 2023, Ameriprise held 4,031 positions worth $305B, down 4.5% from $319B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ameriprise's Q3 2023 filing shows 127 new, 1,527 increased, 2,081 reduced and 148 closed positions. Its largest new stake was TKO Group: 772,651 shares worth $64.9M. The largest sale was Johnson & Johnson, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q3 2023 buy was TKO Group: 772,651 shares worth $64.9M.
- Ameriprise added most to AT&T in Q3 2023, an estimated $501M increase.
- Ameriprise's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $433M.
- Ameriprise fully exited NiSource Inc. Series A Corporate Units in Q3 2023, selling an estimated $73.8M.
- Ameriprise's ten largest holdings make up 16% of its $305B portfolio in Q3 2023.
- Ameriprise opened 127 new positions and closed 148 in Q3 2023.
- Ameriprise's portfolio value fell 4.5% quarter-over-quarter to $305B.
Based on Ameriprise's 13F filing for Q3 2023, filed 14 Nov 2023.